Masood Anbrin, Banerjee Basudeb, Vijayan V K, Ray Arunabha
Department of Pharmacology, Vallabhbhai Patel Chest Institute, University of Delhi, -110007, Delhi, India.
Eur J Pharmacol. 2003 Jan 1;458(1-2):135-9. doi: 10.1016/s0014-2999(02)02688-2.
The involvement of nitric oxide (NO) in stress-induced neurobehavioral changes in rats was evaluated using the elevated plus maze and open field tests. Restraint stress (1 h) reduced both the number of entries and time spent in open arms, with both expressed as percent of controls (no restraint stress), and these changes were reversed with diazepam (1 mg/kg) and the NO precursor, L-arginine (500 and 1000 mg/kg) pretreatment. The nitric oxide synthase inhibitor, N-nitro-L-arginine methyl ester (L-NAME) (50 mg/kg), aggravated restraint stress effects in the elevated plus maze test, whereas the lower dose (10 mg/kg) of the drug attenuated the same. In the open field test, the restraint stress-induced (a) increased entry latency and (b) decreased ambulation and rearing were reversed by diazepam and L-arginine and L-NAME (10 mg/kg), whereas L-NAME (50 mg/kg) aggravated restraint stress effects. The neuronal nitric oxide synthase inhibitor, 7-nitroindazole (10 and 50 mg/kg), did not influence these restraint stress-induced behavioral changes to any significant extent. Biochemical data showed that L-NAME (10 and 50 mg/kg.) induced opposite effects on the total brain nitrate/nitrite content during restraint stress. The results indicate a possible involvement of NO in stress-induced neurobehavioral effects.
采用高架十字迷宫和旷场试验评估一氧化氮(NO)在应激诱导的大鼠神经行为变化中的作用。束缚应激(1小时)减少了进入开放臂的次数和在开放臂中停留的时间,两者均以相对于对照组(无束缚应激)的百分比表示,而地西泮(1毫克/千克)和NO前体L-精氨酸(500和1000毫克/千克)预处理可逆转这些变化。一氧化氮合酶抑制剂N-硝基-L-精氨酸甲酯(L-NAME)(50毫克/千克)在高架十字迷宫试验中加重了束缚应激的影响,而较低剂量(10毫克/千克)的该药物则减轻了这种影响。在旷场试验中,束缚应激诱导的(a)进入潜伏期增加和(b)行走及竖毛减少被地西泮、L-精氨酸和L-NAME(10毫克/千克)逆转,而L-NAME(50毫克/千克)加重了束缚应激的影响。神经元型一氧化氮合酶抑制剂7-硝基吲唑(10和50毫克/千克)在很大程度上未影响这些束缚应激诱导的行为变化。生化数据表明,L-NAME(10和50毫克/千克)在束缚应激期间对全脑硝酸盐/亚硝酸盐含量产生相反的影响。结果表明NO可能参与了应激诱导的神经行为效应。